603148-36-3 Usage
Uses
Used in Pharmaceutical Industry:
Azeliragon is used as a therapeutic agent for the treatment of Alzheimer's disease, aiming to improve cognitive and functional performance in patients by targeting the RAGE receptor and reducing associated neuroinflammation and neurodegeneration.
Used in Clinical Research:
Azeliragon is utilized as a subject of clinical trials to evaluate its efficacy and safety in early-stage Alzheimer's patients, with the goal of understanding its potential benefits and refining its therapeutic applications further.
Check Digit Verification of cas no
The CAS Registry Mumber 603148-36-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,3,1,4 and 8 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 603148-36:
(8*6)+(7*0)+(6*3)+(5*1)+(4*4)+(3*8)+(2*3)+(1*6)=123
123 % 10 = 3
So 603148-36-3 is a valid CAS Registry Number.
InChI:InChI=1/C32H38ClN3O2/c1-4-7-9-32-34-31(25-10-16-28(17-11-25)37-23-8-22-35(5-2)6-3)24-36(32)27-14-20-30(21-15-27)38-29-18-12-26(33)13-19-29/h10-21,24H,4-9,22-23H2,1-3H3
603148-36-3Relevant academic research and scientific papers
CRYSTALLINE FORMS OF [3-(4- -PHENOXY)-PROPYL]-DIETHYL-AMINE
-
Page/Page column 6, (2008/12/04)
The present invention relates to crystalline forms of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethylamine (“COMPOUND I”) useful in the treatment of RAGE mediated diseases.
